 0 Table of Contents |
  1 Home Page |
  2 Business Use Cases |
  3 Domains Overview |
   3.1 Identification |
   3.2 Identification: CMC synthetic data rendering - drug product |
   3.3 Identification: CMC synthetic data rendering - drug product |
   3.4 Identification: CMC synthetic data rendering - drug product |
   3.5 Identification: CMC synthetic data rendering - drug substance |
   3.6 Identification: CMC synthetic data rendering - drug substance |
   3.7 Composition |
   3.8 Composition: CMC synthetic data rendering - drug product |
   3.9 Composition: CMC synthetic data rendering - drug substance |
   3.10 Impurities |
   3.11 Impurities: CMC synthetic data rendering - drug product |
    3.11.1 Impurities: CMC synthetic data rendering - drug substance |
   3.12 Organizations |
   3.13 Organizations: CMC synthetic data rendering |
   3.14 Batch/Lot Information |
   3.15 Batch/Lot Information: CMC synthetic data rendering - drug product |
   3.16 Batch/Lot Information: CMC synthetic data rendering - drug substance |
   3.17 Batch Analysis |
   3.18 Batch Analysis: CMC synthetic data rendering - drug product |
   3.19 Batch Analysis: CMC synthetic data rendering - drug substance |
   3.20 Batch Formula |
   3.21 Batch Formula: CMC synthetic data rendering - drug product |
   3.22 Manufacturing Process |
   3.23 Manufacturing Process: CMC synthetic data rendering - drug product |
   3.24 Manufacturing Process: CMC synthetic data rendering - drug substance |
   3.25 Process Validation |
   3.26 Process Validation: CMC synthetic data rendering - drug product |
   3.27 Process Validation: CMC synthetic data rendering - drug product, biologic |
   3.28 Process Validation: CMC synthetic data rendering - drug substance |
   3.29 Analytical Procedures |
   3.30 Analytical Procedures: CMC synthetic data rendering - drug product |
   3.31 Analytical Procedures: CMC synthetic data rendering - drug substance |
   3.32 Container Closure System |
   3.33 Container Closure System: CMC synthetic data rendering - drug product |
   3.34 Container Closure System: CMC synthetic data rendering - drug substance |
   3.35 Stability Study |
   3.36 Stability Study: CMC synthetic data rendering - drug product |
   3.37 Stability Study: CMC synthetic data rendering - drug substance |
   3.38 Drug Specification |
   3.39 Drug Specification: CMC synthetic data rendering - drug product |
   3.40 Drug Specification: CMC synthetic data rendering - drug substance |
   3.41 Compatibility |
   3.42 Compatibility: CMC synthetic data rendering - drug product |
  4 Best Practices, Resources |
  5 Downloads |
  6 Artifacts Summary |
   6.1 Profile: Bundle - Analytical Procedure |
   6.2 Example: Bundle – Analytical Procedure, product |
   6.3 Example: Bundle – Analytical Procedure, substance |
   6.4 Profile: Bundle - Batch Analysis |
   6.5 Example: Bundle – Batch Analysis, product |
   6.6 Example: Bundle – Batch Analysis, substance |
   6.7 Profile: Bundle - Batch Formula |
   6.8 Example: Bundle - Batch Formula |
   6.9 Profile: Bundle - Product Batch Information |
   6.10 Profile: Bundle - Substance Batch Information |
   6.11 Example: Bundle – Product Batch Information |
   6.12 Example: Bundle – Substance Batch Information |
   6.13 Profile: Bundle - Product Compatibility |
   6.14 Example: Bundle – Product Compatibility |
   6.15 Profile: Bundle - Product Composition |
   6.16 Profile: Bundle - Reference Standards |
   6.17 Example: Bundle – Product Composition |
   6.18 Example: Bundle – Reference Standards, substance |
   6.19 Profile: Bundle - Container Closure System |
   6.20 Example: Bundle - Container Closure System, product |
   6.21 Example: Bundle - Container Closure System, substance |
   6.22 Profile: Bundle - Product Specification |
   6.23 Profile: Bundle - Substance Specification |
   6.24 Example: Bundle – Product Specification |
   6.25 Example: Bundle – Substance Specification |
   6.26 Profile: Bundle - Drug Product |
   6.27 Profile: Bundle - Product Microbiological Attributes |
   6.28 Profile: Bundle - Product Excipients |
   6.29 Profile: Bundle - Substance General Properties |
   6.30 Profile: Bundle - Substance Characterization |
   6.31 Example: Bundle – Drug Product |
   6.32 Example: Bundle – Product Microbiological Attributes |
   6.33 Example: Bundle – Product Excipients |
   6.34 Example: Bundle – Substance General Properties |
   6.35 Example: Bundle – Substance Characterization |
   6.36 Profile: Bundle - Impurities |
   6.37 Example: Bundle - Impurities, product |
   6.38 Example: Bundle - Impurities, substance |
   6.39 Profile: Bundle - Manufacturing |
   6.40 Example: Bundle - Manufacturing, product |
   6.41 Example: Bundle - Manufacturing, substance |
   6.42 Profile: Bundle - Organizations |
   6.43 Example: Bundle - Organizations |
   6.44 Profile: Bundle - Process Validation |
   6.45 Example: Bundle - Process Validation, product |
   6.46 Example: Bundle - Process Validation, biologic product |
   6.47 Example: Bundle - Process Validation, substance |
   6.48 Profile: Bundle - Stability |
   6.49 Example: Bundle – Stability, product |
   6.50 Example: Bundle – Stability, substance |
   6.51 ActivityDefinition - Test |
   6.52 Composition - Drug |
   6.53 DeviceDefinition - Drug |
   6.54 DiagnosticReport - Drug Analysis |
   6.55 DocumentReference - Drug |
   6.56 Ingredient - Drug |
   6.57 ManufacturedItemDefinition - Drug |
   6.58 Medication - Batch Information |
   6.59 MedicinalProductDefinition - Drug Product |
   6.60 Observation - Test Result |
   6.61 ObservationDefinition - Test Method |
   6.62 Organization - Drug |
   6.63 PackagedProductDefinition - Drug |
   6.64 PlanDefinition - Drug |
   6.65 Procedure - Drug |
   6.66 Specimen - Drug |
   6.67 SpecimenDefinition - Drug |
   6.68 Substance - Drug |
   6.69 SubstanceDefinition - Component Drug |
   6.70 ActivityDefinition - Test - example 1 |
   6.71 ActivityDefinition - Test - example 2 |
   6.72 Composition - Drug - example, formulation |
   6.73 Composition - Drug - example, risk |
   6.74 DeviceDefinition - Drug - example |
   6.75 DiagnosticReport - Drug Analysis - example, stability |
   6.76 DocumentReference - Drug - example |
   6.77 Ingredient - Drug - example |
   6.78 ManufacturedItemDefinition - Drug - example 1 |
   6.79 ManufacturedItemDefinition - Drug - example 2 |
   6.80 Medication - Batch Information - example |
   6.81 MedicinalProductDefinition - Drug Product - example |
   6.82 Observation - Test Result - example 1 |
   6.83 Observation - Test Result - example 2 |
   6.84 ObservationDefinition - Test Method - example 1, longTerm25X |
   6.85 ObservationDefinition - Test Method - example 2, Water |
   6.86 Organization - Drug - example |
   6.87 PackagedProductDefinition - Drug - example |
   6.88 PlanDefinition - Drug - example, validation protocol |
   6.89 PlanDefinition - Drug - example, manufacturing plan |
   6.90 PlanDefinition - Drug - example, drug specification |
   6.91 PlanDefinition - Drug - example, manufacturing process |
   6.92 PlanDefinition - Drug - example, stability study protocol |
   6.93 Procedure - Drug - example 1 |
   6.94 Procedure - Drug - example 2 |
   6.95 Specimen - Drug - example |
   6.96 SpecimenDefinition - Drug - example 1 |
   6.97 SpecimenDefinition - Drug - example 2 |
   6.98 SpecimenDefinition - Drug - example 3 |
   6.99 Substance - Drug - example |
   6.100 SubstanceDefinition - Component Drug - example 1 |
   6.101 SubstanceDefinition - Component Drug - example 2 |
   6.102 SubstanceDefinition - Component Drug - example 3 |
   6.103 Extension - Actual Yield |
   6.104 Extension - Actual Yield Unfiltered |
   6.105 Extension - Batch Derived From |
   6.106 Extension - Batch Designation |
   6.107 Extension - Batch Number of Full Shelves |
   6.108 Extension - Batch Number of Partial Shelves |
   6.109 Extension - Batch Number of Vials |
   6.110 Extension - Batch Release Date |
   6.111 Extension - Batch Retest Date |
   6.112 Extension - Batch Storage Duration |
   6.113 Extension - Batch Substance Batch |
   6.114 Extension - Container Orientation |
   6.115 Extension - Formulation Number |
   6.116 Extension - History of Process |
   6.117 Extension - Impurity Origin |
   6.118 Extension - Manufacturing Participant |
   6.119 Extension - Manufacturing Process |
   6.120 Extension - Medication Definition |
   6.121 Extension - Novel Excipient |
   6.122 Extension - Package Definition |
   6.123 Extension - Packaging Date |
   6.124 Extension - Packaging Site |
   6.125 Extension - Plan Document Reference |
   6.126 Extension - Process Parameters |
   6.127 Extension - Process Step Scale |
   6.128 Extension - Qualified Value Criticality |
   6.129 Extension - Qualified Value Display |
   6.130 Extension - Qualified Value Target |
   6.131 Extension - Qualified Value Text |
   6.132 Extension - Site Utilization |
   6.133 Extension - Statistical Model |
   6.134 Extension - Substance Property Parameter |
   6.135 Extension - Substance Property Range |
   6.136 Extension - Suitability For Use |
   6.137 Extension - Target Fill Weight |
   6.138 Extension - Test Comment |
   6.139 Extension - Time Point Description |
   6.140 accelerated40X |
   6.141 accelerated40Y |
   6.142 accelerated40Z |
   6.143 longTerm25Y |
   6.144 longTerm25Z |
   6.145 longTerm30X |
   6.146 longTerm30Y |
   6.147 Assay |
   6.148 Degradation |
   6.149 Description |
   6.150 Identification |
   6.151 Impurities |
   6.152 Microbiological |
   6.153 Uniformity |
   6.154 observation-test-result-longterm25c-initial-1 |
   6.155 observation-test-result-lt25c-i1-degradation-imp2 |
   6.156 observation-test-result-lt25c-i1-degradation-imp3 |
   6.157 observation-test-result-lt25c-i1-degradation-imp-total |
   6.158 observation-test-result-lt25c-i1-degradation-imp-unspecified |
   6.159 observation-test-result-lt25c-i1-microbiological |
   6.160 observation-test-result-lt25c-i1-uniformity |
   6.161 observation-test-result-lt25c-i1-water |
   6.162 Closure Type Terminology |
   6.163 MedicinalProduct Characteristic Type |
   6.164 Medicine Dose Form EDQM |
   6.165 Medicine Route of Administration EDQM |
   6.166 ValueSet - Batch Designation |
   6.167 ValueSet - Container Orientation |
   6.168 ValueSet - Device Property |
   6.169 ValueSet - Device Type |
   6.170 ValueSet - Impurity Origin |
   6.171 ValueSet - Ingredient Function |
   6.172 ValueSet - Manufactured Item Property |
   6.173 ValueSet - Manufacturing Step |
   6.174 ValueSet - Manufacturing Step Scale |
   6.175 ValueSet - Package Property |
   6.176 ValueSet - Plan Type |
   6.177 ValueSet - Process Validation Procedure |
   6.178 ValueSet - Product Site Utilization |
   6.179 ValueSet - Qualified Value Criticality |
   6.180 ValueSet - Test Method |
   6.181 ValueSet - Time Point Description |
   6.182 CodeSystem - Batch Designation |
   6.183 CodeSystem - Characterization Step |
   6.184 CodeSystem - Closure Types |
   6.185 CodeSystem - Color |
   6.186 CodeSystem - Container Orientation |
   6.187 CodeSystem - Control Criticality |
   6.188 CodeSystem - Device Property |
   6.189 CodeSystem - Device Type |
   6.190 CodeSystem - Diagram Type |
   6.191 CodeSystem - Equipment Class |
   6.192 CodeSystem - Goal Priority |
   6.193 CodeSystem - Grade |
   6.194 CodeSystem - ICH M7 Classification |
   6.195 CodeSystem - Impurity Origin |
   6.196 CodeSystem - Impurity Type |
   6.197 CodeSystem - Ingredient Function |
   6.198 CodeSystem - Example Local Codes - Drug |
   6.199 CodeSystem - Manufactured Item Property |
   6.200 CodeSystem - Manufacturing Participant Role |
   6.201 CodeSystem - Manufacturing Step |
   6.202 CodeSystem - Manufacturing Step Scale |
   6.203 CodeSystem - Mutagenicity |
   6.204 CodeSystem - Mutagenicity Classification Type |
   6.205 CodeSystem - Package Property |
   6.206 CodeSystem - Plan Type |
   6.207 CodeSystem - Process Parameter |
   6.208 CodeSystem - Product Name Type |
   6.209 CodeSystem - Product Site Utilization Type |
   6.210 CodeSystem - Qualified Value Criticality |
   6.211 CodeSystem - Report Type |
   6.212 CodeSystem - Specification Type |
   6.213 CodeSystem - Substance Property |
   6.214 CodeSystem - Substance Property Solubility |
   6.215 CodeSystem - Substance Property Type |
   6.216 CodeSystem - Test Category |
   6.217 CodeSystem - Time Point Description |